ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors with high morbidity and mortality. Therefore, it is very important to find potential biomarkers that can effectively predict the prognosis and progression of HCC. Recent studies have shown that anti-silencing function 1B (ASF1...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouyang, Xiaoxi, Lv, Longxian, Zhao, Yalei, Zhang, Fen, Hu, Qingqing, Li, Zuhong, Zhu, Danhua, Li, Lanjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787347/
https://www.ncbi.nlm.nih.gov/pubmed/35087760
http://dx.doi.org/10.3389/fonc.2021.801506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787347/
https://www.ncbi.nlm.nih.gov/pubmed/35087760
http://dx.doi.org/10.3389/fonc.2021.801506

Ejemplares similares